Materialise Nv ADR Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
Analyst Coverage
3analysts covering
FY Revenue (est.)
$285.9Mnext fiscal year
FY EPS (est.)
$0.19next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Third Quarter 2026 Financial Results | 28 Oct 2026 |
Monitoring Framework
Key Performance Indicators
Materialise Medical Segment Revenue Quarterly33.2MTarget: Continued high single-digit to double-digit growth
Consolidated Adjusted EBIT Quarterly2.5MTarget: 10,000,000 to 12,000,000 EUR for FY 2026
Net Cash Position Quarterly72.8MTarget: Maintain positive free cash flow and strong balance sheet flexibility
Watch Items
- Geopolitical uncertainty and foreign currency exchange headwindsTrigger: Revenue growth flatlining or declining below 273,000 kEUR for FY 2026Action: Re-evaluate cost control measures and segment allocation strategies
- Restructuring of non-core businesses (Rapidfit sale and Eyewear transfer)Trigger: Failure to improve consolidated Adjusted EBIT margins toward the guided 10,000 to 12,000 kEUR rangeAction: Assess operational focus and overhead optimization in the Manufacturing segment
Research as of 19 Jun 2026